Versatile applications of fullerenol nanoparticles.
Int J Pharm
; 660: 124313, 2024 Jun 08.
Article
in En
| MEDLINE
| ID: mdl-38857663
ABSTRACT
Nanomaterials have become increasingly important over time as research technology has enabled the progressively precise study of materials at the nanoscale. Developing an understanding of how nanomaterials are produced and tuned allows scientists to utilise their unique properties for a variety of applications, many of which are already incorporated into commercial products. Fullerenol nanoparticles C60(OH)n, 2 ≤ n ≤ 44 are fullerene derivatives and are produced synthetically. They have good biocompatibility, low toxicity and no immunological reactivity. In addition, their nanometre size, large surface area to volume ratio, ability to penetrate cell membranes, adaptable surface that can be easily modified with different functional groups, drug release, high physical stability in biological media, ability to remove free radicals, magnetic and optical properties make them desirable candidates for various applications. This review comprehensively summarises the various applications of fullerenol nanoparticles in different scientific fields such as nanobiomedicine, including antibacterial and antiviral agents, and provides an overview of their use in agriculture and biosensor technology. Recommendations are also made for future research that would further elucidate the mechanisms of fullerenols actions.
Acridine-yellow fullerenol conjugate; Agriculture; Antibiotics; Antioxidants; Copper nanoparticle@fullerenol composite; Fullerenol; Fullerenol C(60)(OH)(20); Fullerenol C(60)(OH)(22-26); Fullerenol C(60)(OH)(24); Fullerenol C(60)(OH)(24-26); Fullerenol C(60)(OH)(36); Fullerenol C(60)(OH)(40); Fullerenol-Doxorubicin Conjugate; Fullerenol-Gentamicin conjugate: C(60)(OH)(12)(GLYMO)(11)(Gentamicin)(0.8); Nanomaterials; Nanomedicine; Plant; Radiation; Sensor
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Int J Pharm
Year:
2024
Document type:
Article